Molecules, Vol. 24, Pages 4566: Development of Asialoglycoprotein Receptor-Targeted Nanoparticles for Selective Delivery of Gemcitabine to Hepatocellular Carcinoma
In conclusion, this study demonstrated site-specific delivery and enhanced in vivo anti-HCC efficacy of gemcitabine by G4, which could function as promising carrier in hepatoma.
Source: Molecules - Category: Chemistry Authors: Anroop B. Nair Jigar Shah Bandar E. Al-Dhubiab Snehal S. Patel Mohamed A. Morsy Vimal Patel Vishal Chavda Shery Jacob Nagaraja Sreeharsha Pottathil Shinu Mahesh Attimarad Katharigatta N. Venugopala Tags: Article Source Type: research
More News: Cancer & Oncology | Carcinoma | Chemistry | Hepatocellular Carcinoma | Liver | Liver Cancer | Nanotechnology | Study | Toxicology | Urology & Nephrology